Page last updated: 2024-08-24

etofibrate and Diabetic Retinopathy

etofibrate has been researched along with Diabetic Retinopathy in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Emmerich, KH; Erbler, H; Goldsteine, J; Görtelmeyer, R; Klindzane, M; Poritis, N; Stelmane, I	1
Freyberger, H; Schatz, H; Schifferdecker, E	1

Trials

1 trial(s) available for etofibrate and Diabetic Retinopathy

Article	Year
[Efficacy and safety of etofibrate in patients with non-proliferative diabetic retinopathy]. Klinische Monatsblatter fur Augenheilkunde, 2009, Volume: 226, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Aged; Clofibric Acid; Diabetic Retinopathy; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Male; Middle Aged; Placebo Effect; Treatment Outcome; Young Adult	2009

Other Studies

1 other study(ies) available for etofibrate and Diabetic Retinopathy

Article	Year
[Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent]. Medizinische Klinik (Munich, Germany : 1983), 1994, Nov-15, Volume: 89, Issue:11 Topics: Adult; Blood Glucose; Clofibric Acid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fundus Oculi; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pilot Projects	1994

Article

Year

[Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent].

Medizinische Klinik (Munich, Germany : 1983), 1994, Nov-15, Volume: 89, Issue:11

Topics: Adult; Blood Glucose; Clofibric Acid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Fundus Oculi; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pilot Projects

1994